Approval · Notice of Compliance 15519 · 2014
FLUODEOXYGLUCOSE 18F INJECTION: Notice of Compliance 15519
Issued April 23, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15519
- Date
- April 23, 2014
- Company
- Isologic Innovative Radiopharmaceuticals Ltd.Dorval, Quebec, Canada
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Diagnostic radiopharmaceutical
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLUODEOXYGLUCOSE 18F INJECTION | Not yet assigned | — |
Medicinal ingredients
- FLUDEOXYGLUCOSE 18F 7,400 MBQ per ML